These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 1311367
21. Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Epstein MA, Morgan AJ, Finerty S, Randle BJ, Kirkwood JK. Nature; ; 318(6043):287-9. PubMed ID: 2999604 [Abstract] [Full Text] [Related]
26. Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. Mackett M, Arrand JR. EMBO J; 1985 Dec 01; 4(12):3229-34. PubMed ID: 3004944 [Abstract] [Full Text] [Related]
27. Comparative immunogenicity studies on Epstein-Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins. Morgan AJ, Epstein MA, North JR. J Med Virol; 1984 Dec 01; 13(3):281-92. PubMed ID: 6327902 [Abstract] [Full Text] [Related]
29. Efficient purification of Epstein-Barr virus membrane antigen gp340 by fast protein liquid chromatography. David EM, Morgan AJ. J Immunol Methods; 1988 Apr 06; 108(1-2):231-6. PubMed ID: 2832478 [Abstract] [Full Text] [Related]
30. The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B. Lees JF, Arrand JE, Pepper SD, Stewart JP, Mackett M, Arrand JR. Virology; 1993 Aug 06; 195(2):578-86. PubMed ID: 8393237 [Abstract] [Full Text] [Related]
36. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J, Pai S, Cotter M, Robertson ES. Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337 [Abstract] [Full Text] [Related]
37. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM. Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474 [Abstract] [Full Text] [Related]
38. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms. Dotsika E, Karagouni E, Sundquist B, Morein B, Morgan A, Villacres-Eriksson M. Scand J Immunol; 1997 Mar 01; 45(3):261-8. PubMed ID: 9122615 [Abstract] [Full Text] [Related]